Cardinal Health (NYSE:CAH) Given New $145.00 Price Target at JPMorgan Chase & Co.

Cardinal Health (NYSE:CAH) had its target price upped by JPMorgan Chase & Co. from $142.00 to $145.00 in a research report report published on Tuesday,Benzinga reports. They currently have a neutral rating on the stock.

A number of other research analysts have also issued reports on CAH. Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a report on Friday, January 10th. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd. UBS Group upped their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a report on Monday, November 4th. TD Cowen raised Cardinal Health from a “hold” rating to a “buy” rating and upped their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, Bank of America raised Cardinal Health from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $132.00 to $145.00 in a report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $136.87.

Cardinal Health Stock Down 0.3 %

CAH stock opened at $127.07 on Tuesday. The business has a 50 day moving average price of $122.35 and a 200 day moving average price of $114.92. The stock has a market cap of $30.70 billion, a price-to-earnings ratio of 23.71, a PEG ratio of 1.46 and a beta of 0.63. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $132.84.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, sell-side analysts anticipate that Cardinal Health will post 7.92 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date is Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.59%. Cardinal Health’s dividend payout ratio is currently 37.69%.

Institutional Trading of Cardinal Health

Several institutional investors and hedge funds have recently made changes to their positions in CAH. Czech National Bank lifted its position in shares of Cardinal Health by 7.0% in the third quarter. Czech National Bank now owns 49,673 shares of the company’s stock valued at $5,490,000 after acquiring an additional 3,259 shares in the last quarter. GAMMA Investing LLC lifted its position in Cardinal Health by 34.0% during the third quarter. GAMMA Investing LLC now owns 3,557 shares of the company’s stock worth $393,000 after buying an additional 902 shares during the period. Exeter Financial LLC lifted its position in Cardinal Health by 0.9% during the third quarter. Exeter Financial LLC now owns 14,757 shares of the company’s stock worth $1,631,000 after buying an additional 128 shares during the period. Alpha Cubed Investments LLC purchased a new position in Cardinal Health during the third quarter worth about $371,000. Finally, Insight Wealth Strategies LLC lifted its position in Cardinal Health by 1.9% during the third quarter. Insight Wealth Strategies LLC now owns 19,483 shares of the company’s stock worth $2,153,000 after buying an additional 365 shares during the period. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.